Posted on May 8, 2021 Science 37 taps a SPAC to go public, with siteless trial specialist valued at a cool $1B
Posted on May 7, 2021 Jasper and its stem cell conditioning antibody earn a ticket to Nasdaq in latest SPAC reverse merger
